Cross-neutralizing human anti-poliovirus antibodies bind the recognition site for cellular receptor

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 50, 2013, Pages 20242-20247

  Chen, Zhaochun ^a   Fischer, Elizabeth R ^b   Kouiavskai, Diana ^c   Hansen, Bryan T ^b   Ludtke, Steven J ^d   Bidzhieva, Bella ^c   Makiya, Michelle ^a   Agulto, Liane ^a   Purcell, Robert H ^a   Chumakov, Konstantin ^c  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Antiviral therapy; Broadly reactive antibodies; Passive immunization; Phage display

Indexed keywords

CELL RECEPTOR; CELLULAR POLIOVIRUS RECEPTOR CD 155; IMMUNOGLOBULIN F(AB) FRAGMENT; NEUTRALIZING ANTIBODY; POLIOMYELITIS VIRUS ANTIBODY; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

ANIMAL CELL; ANTIGEN BINDING; ARTICLE; BINDING SITE; EPITOPE MAPPING; NONHUMAN; NUCLEOTIDE SEQUENCE; PHAGE DISPLAY; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; RECOGNITION; SEROTYPE; VIRION; VIRUS NEUTRALIZATION;

EID: 84890290033     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1320041110     Document Type: Article

References (31)

1. Dowdle WR, De Gourville E, Kew OM, Pallansch MA, Wood DJ (2003) Polio eradication: The OPV paradox. Rev Med Virol 13(5):277-291.
2. Kew OM, Sutter RW, de Gourville EM, Dowdle WR, Pallansch MA (2005) Vaccine-derived polioviruses and the endgame strategy for global polio eradication. Annu Rev Microbiol 59:587-635.
3. Centers for Disease Control and Prevention (CDC) (2009) Update on vaccine-derived polioviruses - worldwide, January 2008-June 2009. MMWR Morb Mortal Wkly Rep 58(36):1002-1006.
4. Hammon WM (1955) Passive immunization against poliomyelitis. Monogr Ser World Health Organ 26:357-370.
5. Chen Z, et al. (2011) Chimpanzee-human monoclonal antibodies for treatment of chronic poliovirus excretors and emergency postexposure prophylaxis. J Virol 85(9):4354-4362.
6. He Y, et al. (2000) Interaction of the poliovirus receptor with poliovirus. Proc Natl Acad Sci USA 97(1):79-84.
7. He Y, et al. (2003) Complexes of poliovirus serotypes with their common cellular receptor, CD155. J Virol 77(8):4827-4835.
8. Zhang P, et al. (2008) Crystal structure of CD155 and electron microscopic studies of its complexes with polioviruses. Proc Natl Acad Sci USA 105(47):18284-18289.
9. Kaplan G, Peters D, Racaniello VR (1990) Poliovirus mutants resistant to neutralization with soluble cell receptors. Science 250(4987):1596-1599.
10. Hogle JM, Chow M, Filman DJ (1985) Three-dimensional structure of poliovirus at 2.9 A resolution. Science 229(4720):1358-1365.
11. Minor PD (1986) Antigenic structure of poliovirus. Microbiol Sci 3(5):141-144.
12. Emini EA, Jameson BA, Lewis AJ, Larsen GR, Wimmer E (1982) Poliovirus neutralization epitopes: Analysis and localization with neutralizing monoclonal antibodies. J Virol 43(3):997-1005.
13. Hogle JM, Filman DJ (1989) The antigenic structure of poliovirus. Philos Trans R Soc Lond B Biol Sci 323(1217):467-478.
14. Minor PD, Ferguson M, Evans DM, Almond JW, Icenogle JP (1986) Antigenic structure of polioviruses of serotypes 1, 2 and 3. J Gen Virol 67(Pt 7):1283-1291.
15. Uhlig H, Rutter G, Dernick R (1985) Self-reactive B lymphocytes detected in young adults, children and newborns after in vitro infection with Epstein-Barr virus. Clin Exp Immunol 62(1):75-84.
16. Uhlig H, Dernick R (1988) Intertypic cross-neutralization of polioviruses by human monoclonal antibodies. Virology 163(1):214-217.
17. Che Z, et al. (1998) Antibody-mediated neutralization of human rhinovirus 14 explored by means of cryoelectron microscopy and X-ray crystallography of virus-Fab complexes. J Virol 72(6):4610-4622.
18. Bostina M, Levy H, Filman DJ, Hogle JM (2011) Poliovirus RNA is released from the capsid near a twofold symmetry axis. J Virol 85(2):776-783.
19. Levy HC, Bostina M, Filman DJ, Hogle JM (2010) Catching a virus in the act of RNA release: A novel poliovirus uncoating intermediate characterized by cryo-electron microscopy. J Virol 84(9):4426-4441.
20. Strauss M, Levy HC, Bostina M, Filman DJ, Hogle JM (2013) RNA transfer from poliovirus 135S particles across membranes is mediated by long umbilical connectors. J Virol 87(7):3903-3914.
21. Lin J, Cheng N, Hogle JM, Steven AC, Belnap DM (2013) Conformational shift of a major poliovirus antigen confirmed by immuno-cryogenic electron microscopy. J Immunol 191(2):884-891.
22. Wimmer E, Hellen CU, Cao X (1993) Genetics of poliovirus. Annu Rev Genet 27:353-436.
23. Harber J, Bernhardt G, Lu H-H, Sgro JY, Wimmer E (1995) Canyon rim residues, including antigenic determinants, modulate serotype-specific binding of polioviruses to mutants of the poliovirus receptor. Virology 214(2):559-570.
24. Tsibane T, et al. (2012) Influenza human monoclonal antibody 1F1 interacts with three major antigenic sites and residues mediating human receptor specificity in H1N1 viruses. PLoS Pathog 8(12):e1003067.
25. Xu R, et al. (2013) A recurring motif for antibody recognition of the receptor-binding site of influenza hemagglutinin. Nat Struct Mol Biol 20(3):363-370.
26. Scheid JF, et al. (2011) Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding. Science 333(6049):1633-1637.
27. Wu X, et al.; NISC Comparative Sequencing Program (2011) Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing. Science 333(6049):1593-1602.
28. Tang G, et al. (2007) EMAN2: an extensible image processing suite for electron microscopy. J Struct Biol 157(1):38-46.
29. Henderson R, et al. (2012) Outcome of the first electron microscopy validation task force meeting. Structure 20(2):205-214.
30. Goddard TD, Huang CC, Ferrin TE (2007) Visualizing density maps with UCSF Chimera. J Struct Biol 157(1):281 -287.
31. Anonymous (1997) Manual for the Virological Investigation of Polio (World Health Organization, Geneva).